Compare MATW & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MATW | CMPS |
|---|---|---|
| Founded | 1850 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 778.7M |
| IPO Year | 1995 | 2020 |
| Metric | MATW | CMPS |
|---|---|---|
| Price | $25.33 | $5.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $26.57 |
| AVG Volume (30 Days) | 174.1K | ★ 2.3M |
| Earning Date | 04-29-2026 | 03-24-2026 |
| Dividend Yield | ★ 4.05% | N/A |
| EPS Growth | ★ 59.07 | N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $1,795,737,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.50 | $2.25 |
| 52 Week High | $29.11 | $8.90 |
| Indicator | MATW | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 34.19 |
| Support Level | $23.70 | $4.91 |
| Resistance Level | $26.04 | $5.38 |
| Average True Range (ATR) | 0.73 | 0.39 |
| MACD | 0.09 | -0.09 |
| Stochastic Oscillator | 71.30 | 10.95 |
Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.